Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.079551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Emmanuel Naveen Raj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Ubiquitin-Conjugating Enzymes, Biomarkers, Tumor, Topotecan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
- National Museum of Marine Biology & Aquarium, Pingtung, Taiwan.
- Center of General Education, Cheng Shiu University, Kaohsiung, Taiwan.
- Center of General Education, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
- Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.
Zitieren
APA
Raj, E. N., Li, C. J., Cheng, S. H., Yong, S. B., Wen, Z. H., & Chiang, A. J. (2026). Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.079551
Vancouver
Raj EN, Li CJ, Cheng SH, Yong SB, Wen ZH, Chiang AJ. Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.079551
BibTeX
@article{Raj2026,
author = {Raj, Emmanuel Naveen and Li, Chia-Jung and Cheng, Shih-Hsuan and Yong, Su-Boon and Wen, Zhi-Hong and Chiang, An-Jen},
title = {Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.079551}
}
EUVIMED